Showing 1 - 10 of 5,091
Persistent link: https://www.econbiz.de/10012433890
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood … pharmaceuticals are launched sooner than non-innovative ones, irrespective of the patent regime in the local market. Using a panel …This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …
Persistent link: https://www.econbiz.de/10011992779
. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …
Persistent link: https://www.econbiz.de/10011509446
Persistent link: https://www.econbiz.de/10011925529
A decade ago, Canadian Government scientists invented a vaccine against Ebola virus (VSV-ZEBOV). 1 That vaccine is based on a live attenuated vesicular stomatitis virus, and has several known advantages over the other vaccine candidates in clinical trials: first, in animals one inoculation...
Persistent link: https://www.econbiz.de/10012996765
Persistent link: https://www.econbiz.de/10013470005
Persistent link: https://www.econbiz.de/10012433548
Persistent link: https://www.econbiz.de/10012433661
Persistent link: https://www.econbiz.de/10012433847